Supporting prostate cancer research

IN FOCUS: A national survey of cancer survivors

Dr Susanna Park, Conjoint Lecturer at the University of NSW and Senior Lecturer at the University of Sydney

Researchers at the University of New South Wales are seeking volunteers who have received neurotoxic chemotherapy (i.e. chemotherapy that causes damage to the nerves) as a treatment for cancer to complete an anonymous online survey. The survey takes around 30 minutes to complete.

The IN FOCUS study investigates the assessment strategies, treatments and risk factors for chemotherapy-induced peripheral neuropathy (CIPN). CIPN is a side-effect of chemotherapy that can lead to early cessation of treatment and lasting disability. Through this survey, we hope to better understand the impact CIPN and other side effects of chemotherapy on the lives of Australian cancer survivors.

Ethics approval has been granted through the Human Research Ethics Advisory (Panel D: Biomedical) at the University of New South Wales.

Who can participate?

People living in Australia who have received neurotoxic chemotherapy in the past for cancer. Chemotherapy could be in progress or completed. Many types of chemotherapy are neurotoxic. If you are unsure if yours fits this category, please contact the researchers by the details below.

This study is currently recruiting participants.

Join us today!

Pathfinder is a unique prostate cancer research register that enables prostate cancer survivors to participate in research for a brighter future with their loved ones.

It will enable researchers to save valuable time and money recruiting participants for their projects, so that they can spend more time delivering health benefits to those in need. Click the button to the right to register!